WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

FDA plans review of Moderna flu vaccine for older adults - UPI.com

Moderna's mRNA-1010 flu vaccine for older adults could be made available by the end of 2026, the pharmaceutical company announced on Friday.

Raccontata dahuffpost.comcnbc.comaljazeera.comupi.com

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
upi.comStai leggendo4 mesi fa

FDA plans review of Moderna flu vaccine for older adults - UPI.com

Moderna's mRNA-1010 flu vaccine for older adults could be made available by the end of 2026, the pharmaceutical company announced on Friday.

originale
cnbc.com4 mesi fa

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season. 

Leggi questa versione → originale
aljazeera.com4 mesi fa

US says that it will review Moderna flu vaccine it previously declined

The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns.

Leggi questa versione → originale
huffpost.com4 mesi fa

FDA Reverses Course, Will Review Moderna's mRNA Flu Vaccine

Moderna said the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 18 febbraio 2026·huffpost.com

    FDA Reverses Course, Will Review Moderna's mRNA Flu Vaccine

    Moderna said the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application.

  2. mercoledì 18 febbraio 2026·cnbc.com

    FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

    The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season. 

  3. mercoledì 18 febbraio 2026·aljazeera.com

    US says that it will review Moderna flu vaccine it previously declined

    The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns.

  4. mercoledì 18 febbraio 2026·upi.com

    FDA plans review of Moderna flu vaccine for older adults - UPI.com

    Moderna's mRNA-1010 flu vaccine for older adults could be made available by the end of 2026, the pharmaceutical company announced on Friday.